Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Droller

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
The Urologic Clinics of North America|July 12, 2002
Current concepts of tumor markers in bladder cancerMichael J Droller
The Journal of Urology|May 16, 2012
A new vision for clinical researchMichael J Droller
The Medical Clinics of North America|March 31, 2004
Primary care update on kidney and bladder cancer: a urologic perspectiveMichael J Droller
Urologic Oncology|April 1, 2014
George Russell Prout Jr., M.D., 1924-2013, founding editor, urologic oncologyMichael J Droller
The Journal of Urology|August 8, 2006
We need to lead and not be ledMichael J Droller
The Journal of Urology|November 6, 2003
Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell linesMichael J Droller
The Journal of Urology|November 17, 2009
Vigilance, vigilance, vigilanceMichael J Droller
The Journal of Urology|July 24, 2002
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrenceMichael J Droller
The Journal of Urology|July 24, 2002
Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancerMichael J Droller
The Journal of Urology|July 24, 2002
Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 yearsMichael J Droller
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
The Urologic Clinics of North America|July 12, 2002
Current concepts of tumor markers in bladder cancerMichael J Droller
The Journal of Urology|May 16, 2012
A new vision for clinical researchMichael J Droller
The Medical Clinics of North America|March 31, 2004
Primary care update on kidney and bladder cancer: a urologic perspectiveMichael J Droller
Urologic Oncology|April 1, 2014
George Russell Prout Jr., M.D., 1924-2013, founding editor, urologic oncologyMichael J Droller
The Journal of Urology|August 8, 2006
We need to lead and not be ledMichael J Droller
The Journal of Urology|November 6, 2003
Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell linesMichael J Droller
The Journal of Urology|November 17, 2009
Vigilance, vigilance, vigilanceMichael J Droller
The Journal of Urology|July 24, 2002
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrenceMichael J Droller
The Journal of Urology|July 24, 2002
Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancerMichael J Droller
The Journal of Urology|July 24, 2002
Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 yearsMichael J Droller
Pageof 8